129 studies found for:    Open Studies | "Nasopharyngeal Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance Program
Conditions: Attenuated Familial Adenomatous Polyposis;   Deleterious Familial Adenomatous Polyposis
Intervention: Other: Chart Review
22 Recruiting Study to Evaluate Multiple Doses in Patients With Nasal Polyposis
Condition: Nasal Polyposis
Interventions: Drug: AK001 low dose;   Drug: AK001 high dose;   Drug: Placebo
23 Not yet recruiting Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Donafenib
24 Recruiting Small Bowel Endoscopic Evaluation in Familial Adenomatous Polyposis (FAP)
Condition: Familial Adenomatous Polyposis
Interventions: Procedure: Duodenoscopy and enteroscopy;   Genetic: Molecular analysis.
25 Recruiting Individualized Elective Neck Irradiation Based on MRI in NPC Patients
Condition: Nasopharyngeal Carcinoma
Interventions: Radiation: Elective neck irradiation;   Radiation: Whole neck irradiation
26 Recruiting Endostar for Locally Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Endostatins;   Radiation: IMRT
27 Recruiting Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era
Condition: Nasopharyngeal Carcinoma
Interventions: Radiation: IMRT;   Drug: Cisplatin
28 Recruiting Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Cetuximab;   Drug: Cisplatin;   Drug: Docetaxel;   Drug: Capecitabine;   Radiation: Radiotherapy
29 Not yet recruiting Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Cisplatin 1;   Drug: Cisplatin 2;   Drug: Docetaxel;   Drug: Xeloda;   Radiation: Intensity-modulated radiotherapy
30 Recruiting Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Cisplatin 2;   Drug: Docetaxel;   Drug: Cisplatin 1;   Radiation: Intensity-modulated radiotherapy
31 Recruiting Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Cisplatin;   Radiation: Intensity-modulated radiotherapy
32 Recruiting Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: PDR001;   Drug: Investigator choice of chemotherapy
33 Recruiting Nasopharyngeal Carcinoma Post IMRT
Condition: Nasopharyngeal Carcinoma
Intervention:
34 Recruiting Endocuff for Surveillance of Serrated Polyposis Syndrome
Condition: Polyposis
Intervention: Device: Endocuff-assisted Colonoscopy
35 Recruiting A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Recombinant Human Endostatin Injection (Endostar);   Drug: Fluorouracil (5-Fu);   Drug: Nedaplatin
36 Not yet recruiting Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China
Condition: Nasopharyngeal Cancinoma (NPC)
Intervention:
37 Recruiting NBI to Detect Post-RT Mucosal Residual NPC
Condition: Nasopharyngeal Carcinoma
Intervention: Device: Laryngoscope with NBI system
38 Recruiting Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Conditions: Current Smoker;   Head and Neck Squamous Cell Carcinoma;   Hypopharyngeal Squamous Cell Carcinoma;   Laryngeal Squamous Cell Carcinoma;   Nasopharyngeal Carcinoma;   Oral Cavity Squamous Cell Carcinoma;   Oropharyngeal Squamous Cell Carcinoma
Interventions: Drug: Bupropion Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Nicotine Replacement;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Drug: Varenicline
39 Recruiting Multicentre, Randomized, Open-Label, Phase III Clinical Trial for Advanced Nasopharyngeal Carcinoma Patients
Condition: Nasopharyngeal Cancer
Interventions: Biological: autologous EBV specific Cytotoxic T Lymphocytes;   Drug: combination IV gemcitabine and IV carboplatin (AUC2)
40 Recruiting Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients
Conditions: Nasopharyngeal Carcinoma;   Malnutrition
Intervention: Drug: cisplatin and docetaxel

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years